| 251 |
23724914 | Acquired resistance to crizotinib from a mutation in CD74-ROS1. | 2013 Jun 20 |
3 |
| 252 |
23769348 | [Clinical research of crizotinib in advanced non-small cell lung cancer]. | 2013 Jun |
2 |
| 253 |
23790969 | Crizotinib in the treatment of non--small-cell lung cancer. | 2013 Sep |
3 |
| 254 |
23918070 | Second-Line Therapy for Advanced NSCLC. | 2013 |
1 |
| 255 |
24047072 | Acquired resistance to crizotinib from a mutation in CD74-ROS1. | 2013 Sep 19 |
1 |
| 256 |
24047073 | Acquired resistance to crizotinib from a mutation in CD74-ROS1. | 2013 Sep 19 |
1 |
| 257 |
24218589 | Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins. | 2013 Nov 26 |
5 |
| 258 |
24345493 | [Clinical significance of ROS1 rearrangements in non-small cell lung cancer]. | 2013 Dec |
1 |
| 259 |
24349229 | Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer. | 2013 |
1 |
| 260 |
22215748 | ROS1 rearrangements define a unique molecular class of lung cancers. | 2012 Mar 10 |
5 |
| 261 |
22500682 | ROS1 as a 'druggable' receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway. | 2012 Apr |
1 |
| 262 |
22585869 | ROS1 gene rearrangement is identified in NSCLC. | 2012 Feb |
1 |
| 263 |
22594847 | Crizotinib in the treatment of non-small-cell lung cancer. | 2012 Jun |
1 |
| 264 |
22617245 | Preclinical rationale for use of the clinically available multitargeted tyrosine kinase inhibitor crizotinib in ROS1-translocated lung cancer. | 2012 Jul |
7 |
| 265 |
22891268 | Response to crizotinib in ROS1-rearranged non-small-cell lung cancer. | 2012 Sep 20 |
1 |
| 266 |
22919003 | Identifying and targeting ROS1 gene fusions in non-small cell lung cancer. | 2012 Sep 1 |
2 |
| 267 |
22989574 | Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology. | 2012 |
4 |
| 268 |
28210128 | Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer. | 2012 |
1 |